These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 468740)

  • 1. Aminoglycoside antibiotics. XIII. Synthesis and activity of 4-deoxy-6'-n-methylamikacin and related compounds.
    Naito T; Nakagawa S; Toda S; Fujisawa K; Kawaguchi H
    J Antibiot (Tokyo); 1979 Jun; 32(6):659-64. PubMed ID: 468740
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance to antibiotic synergism in Streptococcus faecalis: further studies with amikacin and with a new amikacin derivative, 4'-deoxy, 6'-N-methylamikacin.
    Calderwood SB; Wennersten C; Moellering RC
    Antimicrob Agents Chemother; 1981 Apr; 19(4):549-55. PubMed ID: 6264851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased susceptibility to 4'-deoxy-6'-N-methylamikacin (BB-K311) conferred by a mutant plasmid in Escherichia coli.
    Perlin MH; Lerner SA
    Antimicrob Agents Chemother; 1982 Jul; 22(1):78-82. PubMed ID: 6289743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical modification of 3'-deoxyamikacin.
    Iwasawa H; Ikeda D; Kondo S; Umezawa H
    J Antibiot (Tokyo); 1982 Dec; 35(12):1715-8. PubMed ID: 7166538
    [No Abstract]   [Full Text] [Related]  

  • 5. Deoxygenation of aminoglycosides.
    Tsuchiya T
    Jpn J Antibiot; 1979 Dec; 32 Suppl():S129-35. PubMed ID: 398898
    [No Abstract]   [Full Text] [Related]  

  • 6. 3'-Deoxyamikacin and 3',4'-dideoxyamikacin and their antibacterial activities.
    Tsuchiya T; Jikihara T; Miyake T; Umezawa S; Hamada M; Umezawa H
    J Antibiot (Tokyo); 1979 Dec; 32(12):1351-3. PubMed ID: 583467
    [No Abstract]   [Full Text] [Related]  

  • 7. Discovery, chemistry, and activity of amikacin.
    Kawaguchi H
    J Infect Dis; 1976 Nov; 134 SUPPL():S242-8. PubMed ID: 825583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A convenient synthetic pathway for multivalent assembly of aminoglycoside antibiotics starting from amikacin.
    Tanaka H; Nishida Y; Furuta Y; Kobayashi K
    Bioorg Med Chem Lett; 2002 Jul; 12(13):1723-6. PubMed ID: 12067546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amikacin analogs with a fluorinated amino acid side chain.
    Hoshi H; Aburaki S; Iimura S; Yamasaki T; Naito T; Kawaguchi H
    J Antibiot (Tokyo); 1990 Jul; 43(7):858-72. PubMed ID: 2387779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
    Drugeon HB; Courtieu AL
    Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 6'-amidine derivatives of amikacin and dibekacin.
    Iwasawa H; Ikeda D; Kondo S; Umezawa H
    J Antibiot (Tokyo); 1984 Apr; 37(4):428-30. PubMed ID: 6547135
    [No Abstract]   [Full Text] [Related]  

  • 12. [The antibacterial activity of amikacin in comparison with four other aminoglycoside antibiotics (proceedings)].
    Schassan HH
    Zentralbl Bakteriol Orig A; 1976 Aug; 235(1-3):320-8. PubMed ID: 983520
    [No Abstract]   [Full Text] [Related]  

  • 13. 13C-NMR studies on 1-N-[(S)-4-amino-2-hydroxybutyl]kanamycin A (butikacin) and related aminoglycosides.
    Coleman MW; Kinns M; Sewell MJ
    J Antibiot (Tokyo); 1979 Apr; 32(4):355-60. PubMed ID: 468723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuning the regioselectivity of the Staudinger reaction for the facile synthesis of kanamycin and neomycin class antibiotics with N-1 modification.
    Li J; Chen HN; Chang H; Wang J; Chang CW
    Org Lett; 2005 Jul; 7(14):3061-4. PubMed ID: 15987205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Possible errors in the interpretation of bacterial sensitivity to aminoglycoside antibiotics].
    García Hierro P; Ponte Miramontes MC; Soriano García F
    Rev Clin Esp; 1980 Oct; 159(2):87-90. PubMed ID: 7209044
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro susceptibility of gram negative bacteria to amikacin and its comparison with three other aminoglycoside antibiotics.
    Daniel J; Thomas M; Shanmugam J
    Indian J Pathol Microbiol; 1985 Apr; 28(2):115-9. PubMed ID: 3835114
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis and antibacterial activities of 1-N [(S)-omega-amino-2-hydroxyalkyl] kanamycin A derivatives.
    Richardson K; Jevons S; Moore JW; Ross BC; Wright JR
    J Antibiot (Tokyo); 1977 Oct; 30(10):843-6. PubMed ID: 591447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical modification of amikacin at C-4'' with inversion of configuration.
    Albert R; Dax K; Stütz AE; Hildebrandt J
    J Antibiot (Tokyo); 1985 Feb; 38(2):275-8. PubMed ID: 3997674
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of the microbiological activity in vitro of BB-K-8, a new aminoglycoside antibiotic].
    Ravagnan G; Rasura M; Piccolomini R
    Boll Soc Ital Biol Sper; 1976 Sep; 52(18):1440-6. PubMed ID: 1024552
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combined effect of cefotaxime and aminoglycoside antibiotics on Pseudomonas strains and group D streptococci].
    Linda H; Patzer J
    Med Dosw Mikrobiol; 1984; 36(4):223-9. PubMed ID: 6100122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.